Supplementary material for Oh et al. (2000) Proc. Natl. Acad. Sci. USA 97 (6), 2626–2631.


Table 1.

 Primer sequences for reverse transcription–PCR

Gene

5' primers

3' primers

Accession no.

ALK1 (1F/1R)

cttggggagcttcagaagggg

ggtggcctccagcatcagaga

L48015

ALK1 (6F/8R)

tcgtggcatggcgagagtgtg

gcccagatgtctgtccacttg

L48015

Angiopoietin-2

gaaccctctgggagagtactg

gctgctatgcactggtgtctc

AF004326

b

-actin

cctgaaccctaaggccaaccg

gctcatagctcttctccaggg

X03672

Col4a1

ttcgcctccaggaacgactac

tggcagaggcgagcatcatag

J04694

Neo

atgaactgcaggacgaggcagcg

ggcgatagaaggcgatgcgctg

U89673

PAI-1

acagtgggaagagacgccttc

ggtgggcaaggtggacatttc

M33960

tPA

agagcagctctgttggcactg

gagtggcagctcacgaagatg

J03520

uPA

cgcctgctgtccttcagaaac

caagatgagctgctccacctc

M17922

uPA receptor

tccaccgaatggcttccagtg

agacaacacgagggcacacac

X62700

VEGF

gtgcaggctgctgtaacgatg

tgctcctcgaaggatctcctc

M95200

ALK1, activin receptor-like kinase 1; PA, plasminogen activator; PAI-1, PA inhibitor-1; tPA, tissue-type PA; uPA, urokinase-type PA; VEGF, vascular endothelial growth factor.